Fatty acid synthase (FASN), a complex of critical enzymatic proteins in the fatty acid synthesis pathway, is commonly upregulated in tumor cells to support the need for lipids for active proliferation, and increased FASN expression is correlated with drug resistance, tumor metastasis, and reduced survival among individuals with cancer. Here, FASN is linked to neoplasm.